B. Floderus et al., OCCUPATIONAL EXPOSURE TO ELECTROMAGNETIC-FIELDS IN RELATION TO LEUKEMIA AND BRAIN-TUMORS - A CASE-CONTROL STUDY IN SWEDEN, CCC. Cancer causes & control, 4(5), 1993, pp. 465-476
Occupational exposure to low-frequency electromagnetic fields (EMF) wa
s studied in 250 leukemia patients and 261 brain-tumor cases, diagnose
d in 1983-87 and compared with a control group of 1,121 randomly selec
ted men, from the mid-region of Sweden, 1983-87. We based the exposure
assessment on measurements from 1,015 different workplaces. On the ba
sis of the job held longest during the 1 0-year period before diagnosi
s, we found an association between the average, daily, mean level of E
MF and chronic lymphocytic leukemia (CLL). The risk increased with inc
reasing level of exposure. The odds ratios (OR) and the 95 percent con
fidence interval (CI) for three consecutive levels of exposure were: 1
.1 (CI = 0.5-2.3); 2.2 (CI = 1.1-4.3); 3.0 (CI = 1.65. 8), respectivel
y. No association was observed for acute myeloid leukemia (OR = 1.0, C
I = 0.5-1.8; OR = 0.8, CI = 0.4-1.6; OR = 1.0, CI = 0.6-1.9). For brai
n tumors, the corresponding risk estimates were 1.0 (CI = 0.7-1.6); 1.
5 (CI = 1.0-2.2); 1.4 (CI = 0.9-2.1). Different EMF indices were teste
d. Tasks with frequent or large variations between high and low field-
densities (high standard deviation) were more common among CLL subject
s. For brain tumors, a prolonged high level (high median values) showe
d the strongest association. Confounding by place of residence, smokin
g, benzene, ionizing radiation, pesticides, and solvents was evaluated
, and these factors did not seem to have a decisive influence on the a
ssociations. We also analyzed other potential sources of bias. For CLL
, there were indications of an excess number of low-exposure subjects
among non-responders, which, to some extent, may have enhanced but not
caused the risk estimates obtained. Our conclusion is that the study
supports the hypothesis that occupational EMF exposure is a hazard in
the development of certain cancers.